{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:08:58Z","timestamp":1775156938534,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.clon.2016.12.011","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T10:33:06Z","timestamp":1483093986000},"page":"325-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4669-918X","authenticated-orcid":false,"given":"B.","family":"Freudenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clon.2016.12.011_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ecl.2014.02.012","article-title":"Thyrotropin in the development and management of differentiated thyroid cancer","volume":"43","author":"McLeod","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8","key":"10.1016\/j.clon.2016.12.011_bib2","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1210\/jc.2012-1083","article-title":"Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis","volume":"97","author":"McLeod","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clon.2016.12.011_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2007-2215","article-title":"Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage","volume":"93","author":"Haymart","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.clon.2016.12.011_bib4","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/jc.2006-0527","article-title":"Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration","volume":"91","author":"Boelaert","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.clon.2016.12.011_bib5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1210\/jc.2011-2735","article-title":"Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease","volume":"97","author":"Fiore","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.clon.2016.12.011_bib6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/thy.1998.8.737","article-title":"Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry","volume":"8","author":"Cooper","year":"1998","journal-title":"Thyroid"},{"issue":"7\u20138","key":"10.1016\/j.clon.2016.12.011_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/078538902321117760","article-title":"Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer","volume":"34","author":"McGriff","year":"2002","journal-title":"Ann Med"},{"issue":"12","key":"10.1016\/j.clon.2016.12.011_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","article-title":"Outcomes of patients with differentiated thyroid carcinoma following initial therapy","volume":"16","author":"Jonklaas","year":"2006","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.clon.2016.12.011_bib9","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1210\/jc.2010-0161","article-title":"Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial","volume":"95","author":"Sugitani","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.clon.2016.12.011_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/er.2015-1106","article-title":"Role of thyroid hormones in skeletal development and bone maintenance","volume":"37","author":"Bassett","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clon.2016.12.011_bib11","doi-asserted-by":"crossref","first-page":"d2238","DOI":"10.1136\/bmj.d2238","article-title":"Levothyroxine dose and risk of fractures in older adults: nested case-control study","volume":"342","author":"Turner","year":"2011","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.clon.2016.12.011_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1089\/thy.2014.0287","article-title":"Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma","volume":"25","author":"Wang","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.clon.2016.12.011_bib13","first-page":"1232","article-title":"Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin","volume":"81","author":"Kung","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.clon.2016.12.011_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cen.12560","article-title":"Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression","volume":"82","author":"Tournis","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"32","key":"10.1016\/j.clon.2016.12.011_bib15","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1200\/JCO.2013.49.1043","article-title":"Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study","volume":"31","author":"Klein Hesselink","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.clon.2016.12.011_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"issue":"9285","key":"10.1016\/j.clon.2016.12.011_bib17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clon.2016.12.011_bib18","first-page":"334","article-title":"Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine","volume":"77","author":"Biondi","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clon.2016.12.011_bib19","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jcem.83.8.5000","article-title":"Clinical case seminar: reentrant atrioventricular nodal tachycardia induced by levothyroxine","volume":"83","author":"Biondi","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clon.2016.12.011_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/thy.2010.0319","article-title":"Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma","volume":"21","author":"Abdulrahman","year":"2011","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.clon.2016.12.011_bib21","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.25011\/cim.v35i3.16591","article-title":"Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer","volume":"35","author":"Abonowara","year":"2012","journal-title":"Clin Invest Med"},{"issue":"19","key":"10.1016\/j.clon.2016.12.011_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clon.2016.12.011_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/eje.0.1500655","article-title":"Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction","volume":"150","author":"Gullu","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.clon.2016.12.011_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/thy.2008.0428","article-title":"Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate","volume":"19","author":"Panico","year":"2009","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.clon.2016.12.011_bib25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.amjcard.2014.03.008","article-title":"Risk of atrial fibrillation with use of oral and intravenous bisphosphonates","volume":"113","author":"Sharma","year":"2014","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.clon.2016.12.011_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40618-014-0110-9","article-title":"Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?","volume":"37","author":"Williams","year":"2014","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.clon.2016.12.011_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"issue":"9871","key":"10.1016\/j.clon.2016.12.011_bib28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(12)62205-3","article-title":"Controversies in primary treatment of low-risk papillary thyroid cancer","volume":"381","author":"McLeod","year":"2013","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.clon.2016.12.011_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12515","article-title":"Guidelines for the management of thyroid cancer","volume":"81","author":"Perros","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.clon.2016.12.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.clon.2016.12.011_bib31","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1210\/jc.2005-0492","article-title":"A\u00a0single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to\u00a0five years later","volume":"90","author":"Kloos","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.clon.2016.12.011_bib32","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1210\/jc.2006-2566","article-title":"Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer","volume":"92","author":"Hovens","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clon.2016.12.011_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.clon.2016.12.011_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2265.2011.04272.x","article-title":"Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma","volume":"76","author":"Diessl","year":"2012","journal-title":"Clin Endocrinol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655516304824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655516304824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:43:38Z","timestamp":1760543018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655516304824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0936655516304824"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2016.12.011","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}